関連する実験動画

Updated: Feb 17, 2026

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

多剤耐性非小細胞肺がん細胞は,DNAを損傷する薬剤に対する付随感受性を示す

Sara Peixoto da Silva¹, Lúcio Lara Santos², Cristina P R Xavier³

¹i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; Department of Biological Sciences, Faculty of Pharmacy of the University of Porto (FFUP), Porto, Portugal.

|February 15, 2026

まとめ

新しい非小細胞肺がん (NSCLC) モデルでは,多剤耐性 (MDR) のメカニズムが示されています. これらのモデルは,DNAを損傷する薬に対する付随の感受性を明らかにし,NSCLC治療におけるMDRを克服するための新しい戦略を提供します.

科学分野:

腫瘍学腫瘍学
分子生物学は分子生物学である.
薬理学薬理学とは

背景:

多剤耐性 (MDR) は,非小細胞肺がん (NSCLC) の治療効果を著しく損なう.
MDRを克服することは,NSCLC患者の生存率を改善するために重要です.

研究の目的:

耐性メカニズムを調査するためにMDR NSCLCの細胞モデルを確立します.
NSCLCにおけるMDRに対抗するための新しい担保感受性戦略を特定する.

主な方法:

パクリタキセル耐性NSCLC細胞サブラインが発達した (A549-CDR1,A549-CDR2).
プロテオミクプロファイル,MDRフェノタイプ,ATP結合カセット (ABC) トランスポーター活性などを評価した.
評価された細胞死,活性酸素種 (ROS) 産生,DNA損傷.

主要な成果:

確立された細胞サブラインは,独特のプロテオミックプロファイルと,複数の薬物に対するクロスレジスタンスのMDRフェノタイプを示した.
MDR細胞は,ABCトランスポーター発現/活性が増加し,増殖が低下し,ROSが増加し,DNA損傷が増加した.
MDR細胞は,P-glycoprotein (P-gp) サブストラット以外のDNAダメージを与えるエージェントに対して,付随の感受性を示した.

結論:

開発されたNSCLCのMDR細胞系は,MDRを理解するための貴重なモデルとなる.
付随の感受性を利用することは,NSCLCにおけるMDRを克服するための有望な治療戦略です.

キーワード:

担保の感度について DNA損傷によるDNA損傷です.多剤耐性多剤耐性は,多剤耐性多剤耐性多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が,多剤耐性が.小型でない肺がんプラチナベースのセラピータクサン (Taxane) とは

さらに関連する動画

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

関連する概念動画

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Other Unique Bacteria

Other Unique Bacteria

Magnetic bacteria exhibit a directed movement called magnetotaxis, driven by structures called magnetosomes. These magnetosomes consist of chains of magnetic particles made of either magnetite (Fe₃O₄) or greigite (Fe₃S₄) and are organized in a linear conformation by a protein scaffold within invaginations of the cell membrane. The bacteria align along the north–south magnetic field lines, much like a compass needle. They are typically microaerophilic or anaerobic...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...